References
Leibold JE. Drugs having a toxic effect on the optic nerve.Int Ophthalmol Clin. 1971;11:137–157.
Place VA, Thomas JP. Clinical pharmacology of ethambutol.Am Rev Respir Dis. 1963;87:901.
Forbes M, Peets E, Kuck N. Effect of ethambutol on mycobacteria.Ann NY Acad Sci. 1966;135:726.
DeVita EG, Miao M, Sadun A. Optic neuropathy in ethambutol-treated renal tuberculosis.J Clin Neuro-ophthalmol. 1987;7:77–83.
Heng JE, Vorwerk CK, Lessell E, Zurakowski D, Levin LA, Dreyer EB. Ethambutol is toxic to retinal ganglion cells via an excitotoxic pathway.Invest Ophthalmol Vis Sci. 1999;40:190–196.
Yoon YH, Jurg KH, Sadun AA, Shin HC, Kih JH. Ethambutol induced vacuolar changes and neuronal loss in rat retinal cell culture: mediation by endogeneous zinc.Toxicol Appl Pharmacol. 2000;162:107–114.
Peets E, Sweeney W, Place V, Buyske O. The absorption, excretion, and metabolic fate of ethambutol in man.Am Rev Resp Dis. 1965;91:51.
Citron KM. Ethambutol: a review with special reference to ocular toxicity.Tubercle. 1969;50:32–36.
Carr RE, Henkind PE. Ocular manifestations of ethambutol.Arch Ophthalmol. 1962;67:566–571.
DePalma P, Franco F, Bragliani G, et al. The incidence of optic neuropathy in 84 patients treated with ethambutol.Metab Pediatr Syst Ophthalmol. 1989;12:80–82.
Reed MD, Blumer JL. Clinical pharmacology of antitubercular drugs.Pediatr Clin North Am. 1983;30:177–193.
Cardoso ER, Peterson EW. Pituitary apoplexy: a review.Neurosurgery. 1984;14:363–373.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gedik, Ş., Azizler, M., Akova, Y.A. et al. Ethambutol-induced optic neuropathy in a patient with pituitary macroadenoma: Case report. Adv Therapy 20, 319–323 (2003). https://doi.org/10.1007/BF02849797
Issue Date:
DOI: https://doi.org/10.1007/BF02849797